Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe
- PMID: 21900722
- PMCID: PMC3428867
- DOI: 10.3851/IMP1849
Insufficient antiretroviral therapy in pregnancy: missed opportunities for prevention of mother-to-child transmission of HIV in Europe
Abstract
Background: Although mother-to-child transmission (MTCT) rates are at an all-time low in Western Europe, potentially preventable transmissions continue to occur. Duration of antenatal combination antiretroviral therapy (ART) is strongly associated with MTCT risk.
Methods: Data on pregnant HIV-infected women enrolled in the Western and Central European sites of the European Collaborative Study between January 2000 and July 2009 were analysed. The proportion of women receiving no antenatal ART or 1-13 days of treatment was investigated, and associated factors explored using logistic regression models.
Results: Of 2,148 women, 142 (7%) received no antenatal ART, decreasing from 8% in 2000-2003 to 5% in 2004-2009 (χ(2)=8.73; P<0.01). A further 41 (2%) received 1-13 days of ART. One-third (64/171) of women with 'insufficient' (0 or 1-13 days) antenatal ART had a late HIV diagnosis (in the third trimester or intrapartum), but half (85/171) were diagnosed before conception. Pre-term delivery <34 weeks was associated with receipt of no and 1-13 days antenatal ART (adjusted odds ratios [ORs] 2.9 [P<0.01] and 4.5 [P<0.01], respectively). History of injecting drug use was associated with an increased risk of no ART (adjusted OR 2.9; P<0.01) and severe symptomatic HIV disease with a decreased risk (adjusted OR 0.2; P<0.01). MTCT rates were 1.1% (15/1,318) among women with ≥14 days antenatal ART and 7.4% (10/136) among those with insufficient ART.
Conclusions: Over the last 10 years, around one in 11 women in this study received insufficient antenatal ART, accounting for 40% of MTCTs. One-half of these women were diagnosed before conception, suggesting disengagement from care.
© 2011 International Medical Press
Figures
Similar articles
-
Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.Addiction. 2012 Jan;107(1):118-28. doi: 10.1111/j.1360-0443.2011.03609.x. Epub 2011 Oct 12. Addiction. 2012. PMID: 21819473 Free PMC article.
-
Pregnancy outcomes in HIV-positive women in Ukraine, 2000-12 (European Collaborative Study in EuroCoord): an observational cohort study.Lancet HIV. 2015 Sep;2(9):e385-92. doi: 10.1016/S2352-3018(15)00079-X. Epub 2015 Jul 12. Lancet HIV. 2015. PMID: 26423552
-
Progress in prevention of mother-to-child transmission of HIV infection in Ukraine: results from a birth cohort study.BMC Infect Dis. 2009 Apr 7;9:40. doi: 10.1186/1471-2334-9-40. BMC Infect Dis. 2009. PMID: 19351387 Free PMC article.
-
Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.AIDS. 2008 Jan 11;22(2):289-99. doi: 10.1097/QAD.0b013e3282f3d63c. AIDS. 2008. PMID: 18097232
-
Screening for HIV Infection in Pregnant Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Jun 18;321(23):2349-2360. doi: 10.1001/jama.2019.2593. JAMA. 2019. PMID: 31184704
Cited by
-
HIV Screening During Pregnancy in a U.S. HIV Epicenter.Infect Dis Obstet Gynecol. 2020 May 7;2020:8196342. doi: 10.1155/2020/8196342. eCollection 2020. Infect Dis Obstet Gynecol. 2020. PMID: 32454582 Free PMC article.
-
Missed opportunities for prevention of vertical HIV transmission in Canada, 1997-2016: a surveillance study.CMAJ Open. 2018 May 10;6(2):E202-E210. doi: 10.9778/cmajo.20180016. CMAJ Open. 2018. PMID: 29759976 Free PMC article.
-
Prevention of mother-to-child transmission of human immunodeficiency virus among pregnant women using injecting drugs in Ukraine, 2000-10.Addiction. 2012 Jan;107(1):118-28. doi: 10.1111/j.1360-0443.2011.03609.x. Epub 2011 Oct 12. Addiction. 2012. PMID: 21819473 Free PMC article.
-
Missed opportunities for prevention of mother-to-child transmission of HIV-1 in the NISDI Perinatal and LILAC cohorts.Int J Gynaecol Obstet. 2012 Oct;119(1):70-5. doi: 10.1016/j.ijgo.2012.05.026. Epub 2012 Jul 21. Int J Gynaecol Obstet. 2012. PMID: 22819316 Free PMC article. Clinical Trial.
-
Client Characteristics Associated with Desire for Additional Services at Syringe Exchange Programs.J Subst Use. 2022;27(6):604-610. doi: 10.1080/14659891.2021.1967486. Epub 2021 Aug 17. J Subst Use. 2022. PMID: 36644655 Free PMC article.
References
-
- Warszawski J, Tubiana R, Le Chenadec J, et al. Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort. AIDS. 2008;22(2):289–99. - PubMed
-
- Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS. 2008;22(8):973–81. - PubMed
-
- European Collaborative Study The mother-to-child HIV transmission epidemic in Europe: evolving in the East and established in the West. AIDS. 2006;20:1419–27. - PubMed
-
- National Study of HIV in Pregnancy and Childhood, NHS Audit Information Analysis Unit, Children’s HIV Association . Audit Information and Analysis Unit for London. Kent, Surrey and Sussex, Essex, Beds & Herts; 2007. Perinatal transmission of HIV in England 2002-2005.
-
- Deblonde J, Claeys P, Temmerman M. Antenatal HIV screening in Europe: a review of policies. European Journal of Public Health. 2007;17(5):414–8. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical